Search Results | Scholarly Articles, Journals, and E-Books

Results: 30

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells.
Published in:
2014
By:
- Malcherek, G;
- Jin, N;
- Hückelhoven, A G;
- Mani, J;
- Wang, L;
- Gern, U;
- Diehlmann, A;
- Wuchter, P;
- Schmitt, A;
- Chen, B;
- Ho, A D;
- Schmitt, M
Publication type:
journal article
CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Published in:
2014
By:
- Kong, Y;
- Chang, Y-J;
- Liu, Y-R;
- Wang, Y-Z;
- Jiang, Q;
- Jiang, H;
- Qin, Y-Z;
- Hu, Y;
- Lai, Y-Y;
- Duan, C-W;
- Hong, D-L;
- Huang, X-J
Publication type:
Letter
Calreticulin mutations and long-term survival in essential thrombocythemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2300, doi. 10.1038/leu.2014.148
By:
- Tefferi, A;
- Wassie, E A;
- Lasho, T L;
- Finke, C;
- Belachew, A A;
- Ketterling, R P;
- Hanson, C A;
- Pardanani, A;
- Gangat, N;
- Wolanskyj, A P
Publication type:
Article
A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2304, doi. 10.1038/leu.2014.218
By:
- Venner, C P;
- Gillmore, J D;
- Sachchithanantham, S;
- Mahmood, S;
- Lane, T;
- Foard, D;
- Rannigan, L;
- Gibbs, S D J;
- Pinney, J H;
- Whelan, C J;
- Lachmann, H J;
- Hawkins, P N;
- Wechalekar, A D
Publication type:
Article
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2427, doi. 10.1038/leu.2014.304
By:
- Allegra, D;
- Bilan, V;
- Garding, A;
- Zucknick, M;
- Döhner, H;
- Stilgenbauer, S;
- Kuchenbauer, F;
- Mertens, D
Publication type:
Article
Risk of myeloid neoplasms after solid organ transplantation.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2317, doi. 10.1038/leu.2014.132
By:
- Morton, L M;
- Gibson, T M;
- Clarke, C A;
- Lynch, C F;
- Anderson, L A;
- Pfeiffer, R;
- Landgren, O;
- Weisenburger, D D;
- Engels, E A
Publication type:
Article
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2367, doi. 10.1038/leu.2014.137
By:
- Rossille, D;
- Gressier, M;
- Damotte, D;
- Maucort-Boulch, D;
- Pangault, C;
- Semana, G;
- Le Gouill, S;
- Haioun, C;
- Tarte, K;
- Lamy, T;
- Milpied, N;
- Fest, T
Publication type:
Article
Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2403, doi. 10.1038/leu.2014.235
By:
- Sarkaria, S M;
- Christopher, M J;
- Klco, J M;
- Ley, T J
Publication type:
Article
Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2388, doi. 10.1038/leu.2014.273
By:
- Malcherek, G;
- Jin, N;
- Hückelhoven, A G;
- Mani, J;
- Wang, L;
- Gern, U;
- Diehlmann, A;
- Wuchter, P;
- Schmitt, A;
- Chen, B;
- Ho, A D;
- Schmitt, M
Publication type:
Article
Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2324, doi. 10.1038/leu.2014.133
By:
- Kumar, V;
- Palermo, R;
- Talora, C;
- Campese, A F;
- Checquolo, S;
- Bellavia, D;
- Tottone, L;
- Testa, G;
- Miele, E;
- Indraccolo, S;
- Amadori, A;
- Ferretti, E;
- Gulino, A;
- Vacca, A;
- Screpanti, I
Publication type:
Article
Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2413, doi. 10.1038/leu.2014.248
By:
- Usmani, S Z;
- Zhang, Q;
- Stratton, K;
- Qu, P;
- Yaccoby, S;
- Hansen, E;
- Steward, D;
- Panozzo, S;
- Petty, N;
- Hoering, A;
- Waheed, S;
- Van Rhee, F;
- Crowley, J;
- Barlogie, B
Publication type:
Article
Next generation treatment of acute graft-versus-host disease.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2283, doi. 10.1038/leu.2014.195
By:
- Magenau, J;
- Reddy, P
Publication type:
Article
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2292, doi. 10.1038/leu.2014.272
By:
- Schmidt, M;
- Rinke, J;
- Schäfer, V;
- Schnittger, S;
- Kohlmann, A;
- Obstfelder, E;
- Kunert, C;
- Ziermann, J;
- Winkelmann, N;
- Eigendorff, E;
- Haferlach, T;
- Haferlach, C;
- Hochhaus, A;
- Ernst, T
Publication type:
Article
The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2402, doi. 10.1038/leu.2014.230
By:
- Kastritis, E;
- Moulopoulos, L A;
- Terpos, E;
- Koutoulidis, V;
- Dimopoulos, M A
Publication type:
Article
WTAP is a novel oncogenic protein in acute myeloid leukemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2427, doi. 10.1038/leu.2014.290
By:
- Bansal, H;
- Yihua, Q;
- Iyer, S P;
- Ganapathy, S;
- Proia, D A;
- Penalva, L O;
- Uren, P J;
- Suresh, U;
- Carew, J S;
- Karnad, A B;
- Weitman, S;
- Tomlinson, G E;
- Rao, M K;
- Kornblau, S M;
- Bansal, S
Publication type:
Article
Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2418, doi. 10.1038/leu.2014.253
By:
- Platzbecker, U;
- Sekeres, M A;
- Kantarjian, H;
- Giagounidis, A;
- Mufti, G J;
- Jia, C;
- Yang, A S;
- Fenaux, P
Publication type:
Article
Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2425, doi. 10.1038/leu.2014.274
By:
- Rashidi, A;
- Fisher, S I
Publication type:
Article
CD34+CD38−CD58− cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2398, doi. 10.1038/leu.2014.228
By:
- Kong, Y;
- Chang, Y-J;
- Liu, Y-R;
- Wang, Y-Z;
- Jiang, Q;
- Jiang, H;
- Qin, Y-Z;
- Hu, Y;
- Lai, Y-Y;
- Duan, C-W;
- Hong, D-L;
- Huang, X-J
Publication type:
Article
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2311, doi. 10.1038/leu.2014.227
By:
- Palladini, G;
- Milani, P;
- Foli, A;
- Vidus Rosin, M;
- Basset, M;
- Lavatelli, F;
- Nuvolone, M;
- Obici, L;
- Perlini, S;
- Merlini, G
Publication type:
Article
FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2376, doi. 10.1038/leu.2014.126
By:
- Sehgal, L;
- Mathur, R;
- Braun, F K;
- Wise, J F;
- Berkova, Z;
- Neelapu, S;
- Kwak, L W;
- Samaniego, F
Publication type:
Article
Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2344, doi. 10.1038/leu.2014.136
By:
- Sakurai, M;
- Kunimoto, H;
- Watanabe, N;
- Fukuchi, Y;
- Yuasa, S;
- Yamazaki, S;
- Nishimura, T;
- Sadahira, K;
- Fukuda, K;
- Okano, H;
- Nakauchi, H;
- Morita, Y;
- Matsumura, I;
- Kudo, K;
- Ito, E;
- Ebihara, Y;
- Tsuji, K;
- Harada, Y;
- Harada, H;
- Okamoto, S
Publication type:
Article
Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2395, doi. 10.1038/leu.2014.226
By:
- Ojha, J;
- Secreto, C;
- Rabe, K;
- Ayres-Silva, J;
- Tschumper, R;
- Dyke, D V;
- Slager, S;
- Fonseca, R;
- Shanafelt, T;
- Kay, N;
- Braggio, E
Publication type:
Article
Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2273, doi. 10.1038/leu.2014.271
By:
- Dispenzieri, A
Publication type:
Article
Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2422, doi. 10.1038/leu.2014.240
By:
- Rahmé, R;
- Thomas, X;
- Recher, C;
- Vey, N;
- Delaunay, J;
- Deconinck, E;
- Hirsch, P;
- Bordessoule, D;
- Micol, J-B;
- Stamatoullas, A;
- Mariette, C;
- Pautas, C;
- Bories, P;
- Marolleau, J-P;
- Hunault-Berger, M;
- Fegueux, N;
- Raffoux, E;
- Dombret, H;
- Degos, L;
- Fenaux, P
Publication type:
Article
AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2416, doi. 10.1038/leu.2014.249
By:
- Nieborowska-Skorska, M;
- Flis, S;
- Skorski, T
Publication type:
Article
A revised definition for cure of childhood acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2336, doi. 10.1038/leu.2014.142
By:
- Pui, C H;
- Pei, D;
- Campana, D;
- Cheng, C;
- Sandlund, J T;
- Bowman, W P;
- Hudson, M M;
- Ribeiro, R C;
- Raimondi, S C;
- Jeha, S;
- Howard, S C;
- Bhojwani, D;
- Inaba, H;
- Rubnitz, J E;
- Metzger, M L;
- Gruber, T A;
- Coustan-Smith, E;
- Downing, J R;
- Leung, W H;
- Relling, M V
Publication type:
Article
Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2276, doi. 10.1038/leu.2014.211
By:
- Corces-Zimmerman, M R;
- Majeti, R
Publication type:
Article
Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2355, doi. 10.1038/leu.2014.131
By:
- Klar, R;
- Schober, S;
- Rami, M;
- Mall, S;
- Merl, J;
- Hauck, S M;
- Ueffing, M;
- Admon, A;
- Slotta-Huspenina, J;
- Schwaiger, M;
- Stevanović, S;
- Oostendorp, R A J;
- Busch, D H;
- Peschel, C;
- Krackhardt, A M
Publication type:
Article
Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2406, doi. 10.1038/leu.2014.237
By:
- Maury, S;
- Rosenzwajg, M;
- Redjoul, R;
- Marcais, A;
- Xhaard, A;
- Cherai, M;
- Cabanne, L;
- Churlaud, G;
- Suarez, F;
- Socié, G;
- Gregoire, L;
- Debbache, K;
- Bernard, C;
- Beaumont, J-L;
- Azar, N;
- Boyer, O;
- Roudot-Thoraval, F;
- Cohen, J L;
- Cordonnier, C;
- Lemoine, F M
Publication type:
Article
Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2410, doi. 10.1038/leu.2014.232
By:
- Heuck, C J;
- Qu, P;
- van Rhee, F;
- Waheed, S;
- Usmani, S Z;
- Epstein, J;
- Zhang, Q;
- Edmondson, R;
- Hoering, A;
- Crowley, J;
- Barlogie, B
Publication type:
Article

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells.

CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Calreticulin mutations and long-term survival in essential thrombocythemia.

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.

Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.

Risk of myeloid neoplasms after solid organ transplantation.

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8<sup>+</sup> T cells.

Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma.

Next generation treatment of acute graft-versus-host disease.

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma.

WTAP is a novel oncogenic protein in acute myeloid leukemia.

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.

Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?

CD34<sup>+</sup>CD38<sup>−</sup>CD58<sup>−</sup> cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis.

Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.

AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells.

A revised definition for cure of childhood acute lymphoblastic leukemia.

Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.